S 537, "The Smarter Lunchroom Act," requires New Jersey public and nonpublic schools to adopt simple, low-cost strategies from The Smarter Lunchroom Movement to promote healthier student meal choices. It directs the Commissioner of Education to support schools in implementing specific changes, such as placing fruits near cash registers, using creative names for vegetables, and positioning nutritious foods first in serving lines. The bill also mandates that the Department of Education provide clear, plain-language online resources about these strategies, including a self-assessment tool. This directly affects over 1.37 million students in New Jersey schools, where nearly 25% of children aged 10-17 are overweight or obese, aiming to improve cafeteria habits through evidence-based design.
This bill requires New Jersey Medicaid to reimburse healthcare providers for remote patient monitoring services used with pregnant Medicaid beneficiaries who cannot receive in-person care. It defines remote monitoring as securely collecting health data (like blood pressure, glucose levels, or weight) through digital tools and transmitting it to providers. The law directly affects pregnant Medicaid patients and their healthcare providers by mandating coverage for these services when medically necessary. This creates a concrete policy change by expanding Medicaid reimbursement to include this technology-based care for a specific vulnerable group.
This bill (S 574) requires New Jersey's Division of Developmental Disabilities (DDD) to create and maintain a publicly accessible list of all its programs and services for individuals with developmental disabilities. The list must include detailed descriptions of services (such as federal waiver programs, self-directed services, and community care options), eligibility requirements (including Medicaid needs and care levels), and information on transitional planning and guardianship. DDD must make the list available online, in print upon request, and update it regularly to reflect current offerings. This directly affects families and individuals seeking support by providing clear, centralized information about available services and how to qualify.
S 1422 extends the deadline for enrolling a newborn infant in health benefits coverage from 60 to 90 days after birth. This change directly affects parents or guardians enrolled in family health insurance plans who must submit birth notification and required payments to maintain continuous coverage for their newborn. The bill modifies existing law to provide an additional 30 days for completing enrollment, ensuring families have more time to secure coverage without gaps. This adjustment applies specifically to family-type health insurance contracts under New Jersey's statutory framework.
This bill requires New Jersey public school districts with grades 9-12 to integrate bleed control instruction into their existing health and physical education curriculum, as part of the state's Comprehensive Health and Physical Education standards. It directly affects high school students by adding practical skills for managing severe bleeding injuries. School districts may choose free, non-certification training programs to meet this requirement. The law takes effect immediately, with implementation beginning in the first full school year after enactment. This is a concrete curriculum change focused on student safety, not a broader policy or commentary.
This bill requires all New Jersey hospitals offering inpatient maternity services to maintain two specific designations: a Baby-Friendly Hospital designation from Baby-Friendly USA and a Mother-Friendly Hospital designation from the Improving Birth Coalition. Hospitals must meet these requirements starting two years after the bill takes effect (which is immediate) to continue providing maternity care. The law directly affects hospitals with maternity departments, making these designations mandatory rather than optional. It focuses on policy compliance, not on specific patient outcomes or program details.
This bill requires New Jersey's Commissioner of Banking and Insurance to create a single, standardized form for network providers (like doctors and pharmacies) to request prior authorization for prescription drug coverage. Payers (insurance companies) must accept this standard form in both paper and electronic formats for all prescription drug benefit requests. The law directly affects providers needing authorization and payers handling those requests, replacing inconsistent forms with a uniform system. It aims to simplify the process for healthcare providers seeking insurance coverage approval for medications. The bill takes effect immediately upon enactment.
This bill requires New Jersey's Department of Health to maintain an emergency insulin stockpile with the 10 most common insulin types used by residents, reevaluated quarterly. It creates a program to provide one emergency 30-day insulin supply per year at cost to residents whose supply runs out before their next prescription, with reimbursement options from health plans. The bill also updates insurance coverage requirements to mandate benefits for one emergency insulin supply annually under health plans. It applies directly to New Jersey residents facing insulin shortages and establishes clear limits on emergency dispensing to prevent overuse.
This bill prohibits health insurers, third-party administrators, and state health benefit programs from requiring prior approval or precertification for covered prenatal ultrasounds. It applies only when the ultrasound is prescribed by a licensed provider and already covered under a health plan. The law directly affects insurance companies, state programs like the State Health Benefits Program, and school employee health plans. It takes effect immediately for new health benefit plans.
This bill requires health insurers in New Jersey to cover medically necessary treatments for tick-borne diseases, including long-term antibiotic therapy (beyond four weeks) and ongoing testing. It directly affects insurers (hospital, medical, health service corporations, and individual policies) and policyholders diagnosed with conditions like Lyme disease (caused by *borrelia burgdorferi*), chronic infections, or other CDC-recognized tick-borne illnesses. Insurers cannot deny coverage solely because treatment is experimental or uses unapproved drugs, provided the treatment is recognized by medical guidelines or peer-reviewed research. The law applies to all relevant insurance contracts issued or renewed in New Jersey after its effective date.
